Chengzhi Shareholding Co Ltd (SHE:000990) — Market Cap & Net Worth
Market Cap & Net Worth: Chengzhi Shareholding Co Ltd (000990)
Chengzhi Shareholding Co Ltd (SHE:000990) has a market capitalization of $2.24 Billion (CN¥15.31 Billion) as of May 2, 2026. Listed on the SHE stock exchange, this China-based company holds position #5853 globally and #1235 in its home market, demonstrating a 5.53% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chengzhi Shareholding Co Ltd's stock price CN¥12.60 by its total outstanding shares 1215237535 (1.22 Billion). Analyse Chengzhi Shareholding Co Ltd (000990) cash conversion ratio to see how efficiently the company converts income to cash.
Chengzhi Shareholding Co Ltd Market Cap History: 2015 to 2026
Chengzhi Shareholding Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $4.28 Billion to $2.24 Billion (-5.72% CAGR).
Chengzhi Shareholding Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chengzhi Shareholding Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.12x
Chengzhi Shareholding Co Ltd's market cap is 0.12 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.98x
Chengzhi Shareholding Co Ltd's market cap is 5.98 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.28 Billion | $4.04 Billion | $137.88 Million | 1.06x | 31.05x |
| 2016 | $2.62 Billion | $2.57 Billion | $110.78 Million | 1.02x | 23.61x |
| 2017 | $2.91 Billion | $5.69 Billion | $808.51 Million | 0.51x | 3.60x |
| 2018 | $2.05 Billion | $5.87 Billion | $849.32 Million | 0.35x | 2.41x |
| 2019 | $2.58 Billion | $6.91 Billion | $442.55 Million | 0.37x | 5.84x |
| 2020 | $2.07 Billion | $9.73 Billion | $355.08 Million | 0.21x | 5.82x |
| 2021 | $2.76 Billion | $12.18 Billion | $1.01 Billion | 0.23x | 2.73x |
| 2022 | $1.53 Billion | $11.72 Billion | $50.93 Million | 0.13x | 30.11x |
| 2023 | $1.45 Billion | $12.42 Billion | $177.40 Million | 0.12x | 8.18x |
| 2024 | $1.38 Billion | $11.07 Billion | $230.59 Million | 0.12x | 5.98x |
Competitor Companies of 000990 by Market Capitalization
Companies near Chengzhi Shareholding Co Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Chengzhi Shareholding Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Chengzhi Shareholding Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Chengzhi Shareholding Co Ltd's market cap moved from $4.28 Billion to $ 2.24 Billion, with a yearly change of -5.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.24 Billion | +59.09% |
| 2025 | CN¥1.41 Billion | +2.19% |
| 2024 | CN¥1.38 Billion | -5.01% |
| 2023 | CN¥1.45 Billion | -5.39% |
| 2022 | CN¥1.53 Billion | -44.37% |
| 2021 | CN¥2.76 Billion | +33.39% |
| 2020 | CN¥2.07 Billion | -19.97% |
| 2019 | CN¥2.58 Billion | +25.99% |
| 2018 | CN¥2.05 Billion | -29.65% |
| 2017 | CN¥2.91 Billion | +11.39% |
| 2016 | CN¥2.62 Billion | -38.91% |
| 2015 | CN¥4.28 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Chengzhi Shareholding Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.24 Billion USD |
| MoneyControl | $2.24 Billion USD |
| MarketWatch | $2.24 Billion USD |
| marketcap.company | $2.24 Billion USD |
| Reuters | $2.24 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Chengzhi Shareholding Co Ltd
Chengzhi Co., Ltd. engages in the clean energy, semiconductor display material, medical healthcare, and life science businesses in China. The company produces and sells gas products, including carbon monoxide, syngas, butane, isobutanal, ethane, propane, crude benzene, ethylene, hydrogen, propylene, methanol, butylene glycol, Butanoctyl, diolefin, and other chemicals. It also produces and sells l… Read more